Literature DB >> 27598330

Current Practices in Ocular Toxoplasmosis: A Survey of Brazilian Uveitis Specialists.

Fábio Barreto Morais1, Tiago Eugênio Faria E Arantes2, Cristina Muccioli1.   

Abstract

PURPOSE: To describe treatment practices for ocular toxoplasmosis among members of the Brazilian Uveitis Society.
METHODS: An online questionnaire sent to specialists, between October 2014 and March 2015.
RESULTS: Most respondents (67.9%) treat all active cases. Most specialists consider visual acuity <20/200 (88.2%), severe vitreous inflammation (94.1%), and ocular disease during acquired infection (88.2%) as absolute indications for treatment. Systemic steroids are associated with anti-toxoplasmic therapy in most cases by 50.9% of the respondents. For immunocompetent individuals, 57.4% of the respondents chose trimethoprim/sulfamethoxazole. Classical therapy (sulfadiazine/pyrimethamine) is preferred most for patients with central lesions (70.4%), immunosuppression (68.4%), acquired infection (70.4%), and atypical forms (74.1%). For patients with frequent relapses, 84.9% of the respondents preferred antibiotic prophylaxis.
CONCLUSIONS: Treatment patterns of ocular toxoplasmosis are not uniform among Brazilian specialists. Most specialists treat all cases of active retinochoroiditis. Typical cases are more frequently treated with trimethoprim/sulfamethoxazole. However, classical therapy is the regimen of choice when lesions are considered more severe.

Entities:  

Keywords:  Antibiotics; ocular toxoplasmosis; practices; specialists; survey; treatment; uveitis

Mesh:

Substances:

Year:  2016        PMID: 27598330     DOI: 10.1080/09273948.2016.1215471

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

Review 1.  Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications.

Authors:  João Paulo Assolini; Virginia Márcia Concato; Manoela Daiele Gonçalves; Amanda Cristina Machado Carloto; Ivete Conchon-Costa; Wander Rogério Pavanelli; Francine Nesello Melanda; Idessania Nazareth Costa
Journal:  Parasitol Res       Date:  2017-05-05       Impact factor: 2.289

2.  Biological Diagnosis of Ocular Toxoplasmosis: a Nine-Year Retrospective Observational Study.

Authors:  Valentin Greigert; Alexander W Pfaff; Arnaud Sauer; Denis Filisetti; Ermanno Candolfi; Odile Villard
Journal:  mSphere       Date:  2019-09-25       Impact factor: 4.389

3.  Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis.

Authors:  Rodrigo Jorge; Igor Neves Coelho; Armando Silva-Cunha; Gabriella Maria Fernandes Cunha; Ingrid U Scott; Silvia Ligório Fialho; João Marcello Furtado
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.